Edition:
United Kingdom

Dermira Inc (DERM.OQ)

DERM.OQ on NASDAQ Stock Exchange Global Select Market

14.10USD
20 Mar 2019
Change (% chg)

$-0.03 (-0.21%)
Prev Close
$14.13
Open
$13.86
Day's High
$14.15
Day's Low
$13.66
Volume
659,363
Avg. Vol
318,633
52-wk High
$14.89
52-wk Low
$6.00

Chart for

About

Dermira, Inc. is a biopharmaceutical company. The Company is focused on the development of therapeutic solutions in medical dermatology to treat skin conditions, such as hyperhidrosis, psoriasis and acne. Its portfolio includes three late-stage product candidates: Cimzia (certolizumab pegol), glycopyrronium tosylate and... (more)

Overall

Beta: --
Market Cap(Mil.): $1,130.87
Shares Outstanding(Mil.): 41.59
Dividend: --
Yield (%): --

Financials

  DERM.OQ Industry Sector
P/E (TTM): -- 69.32 32.54
EPS (TTM): -2.65 -- --
ROI: -21.03 8.89 13.82
ROE: -31.39 10.00 15.25

BRIEF-Dermira Inc Entered Into First Amendment To License Agreement With Roche

* DERMIRA INC - ENTERED INTO FIRST AMENDMENT TO LICENSE AGREEMENT WITH ROCHE

28 Feb 2019

Earnings vs. Estimates